A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis

BACKGROUND: Treosulfan, an alkylating agent, has demonstrated activity in recurrent ovarian carcinoma. It is equieffective as oral (p.o.) and intravenous (i.v.) formulation. To explore the preference and compliance of elderly patients regarding p.o. or i.v. treosulfan for the treatment of relapsed o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahner, Sven, Oskay-Özcelik, Gülten, Heidrich-Lorsbach, Elke, Fuxius, Stefan, Sommer, Harald, Klare, Peter, Belau, Antje, Ruhmland, Birgit, Heuser, Thomas, Kölbl, Heinz, Markmann, Susanne, Sehouli, Jalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397225/
https://www.ncbi.nlm.nih.gov/pubmed/22526159
http://dx.doi.org/10.1007/s00432-012-1221-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397225/
https://www.ncbi.nlm.nih.gov/pubmed/22526159
http://dx.doi.org/10.1007/s00432-012-1221-3

Ejemplares similares